Reliable identification of Staphylococcus aureus is of major concern in clinical microbiological diagnostics. The nuc gene, which encodes thermonuclease, is widely used as a specific target for the identification of S. aureus by PCR (Maes et al., 2002; Louie et al., 2002) . Numerous in-house PCRbased assays targeting the nuc gene alone or in combination with the mecA gene have been described for fast screening or identification of meticillin-susceptible S. aureus (MSSA) and meticillin-resistant S. aureus (MRSA) (Elsayed et al., 2003; Costa et al., 2005; Thomas et al., 2007) .
Several years ago, van Leeuwen et al. (2008) reported an MRSA isolate with partial deletion of the nuc gene, resulting in a nuc-negative PCR and false-negative MRSA result. We have also experienced S. aureus isolates that are negative for the nuc gene on PCR as a diagnostic problem. In our laboratory, specimens are routinely cultured and S. aureus identified by either antibody-mediated agglutination (Staphaurex) or a plasma coagulase test. Isolates that demonstrate cefoxitin or tetracycline resistance by disc diffusion are further examined using duplex in-house real-time PCR to detect the mecA and nuc genes. The primers and probes used for mecA and nuc gene amplification were designed using Primer Express version 3.0 (Applied Biosystems). The oligo sequences of the mecA and nuc assays are as follows: MecA forward primer 59-TTAGATTGG-GATCATAGCGTCATTAT-39; MecA reverse primer 59-AATTCCACATTGTT-TCGGTCTAAAA-39; MecA probe 59-VIC-CCAGGAATGCAGAAAGACCAAA-GCATACA-TAMRA-39; Nuc forward primer 59-GGGTTGATAC-GCCAGAAACG-39; Nuc reverse primer 59-TGATGCTTCTTTGCCAAATGG-39; Nuc probe 59-FAM-TGAAACCGAATAC-GCCTGT-MGB-39.
The 25 ml reactions are run in duplicate and contain 16 TaqMan Fast Universal PCR Master Mix, 26 No AmpErase UNG (Applied Biosystems), 1000 nM of each primer and 200 nM of the probe, and 5 ml sample DNA. Amplification of the 113 and 65 bp products is performed using the 7500 Fast Real-Time PCR System (Applied Biosystems) using the following protocol: initial heat activation of the enzyme at 95 uC for 20 s, followed by 45 cycles of denaturation at 95 u C for 3 s and annealing/extension at 60 u C for 30 s.
During a period of 3 years, we have observed ten clinical isolates phenotypically identified as S. aureus that subsequently tested negative in nuc real-time PCR. The occurrence of these nuc-negative S. aureus isolates is extremely rare (less than 1 % of all S. aureus isolates). In all cases, VITEK 2, MALDI-TOF mass spectrometry (SARAMIS) and partial 16S rRNA gene sequencing (MicroSEQ 500 16S rDNA Bacterial Identification System; Applied Biosystems) confirmed the identity as S. aureus. All ten isolates were negative for mecA and were classified as MSSA. The isolates were from nonhospitalized patients and there was no clustering in time or place.
DNA sequence analysis of part of the nuc gene was performed on the ten isolates. Primers were designed in the flanking regions of the binding sites of the primers used in the nuc-specific real-time PCR assay in order to amplify the region. Sequences showed marked heterogeneity on primers and probe annealing sites as compared with sequences annotated at GenBank (Fig. 1). BLAST screening of the sequenced area of the nuc gene resulted in only one very similar sequence (accession no. FR821777.2). However, alignment of this sequence with the query sequence showed minor discrepancies. The partial nuc sequences are deposited in GenBank. The sequence variations did not result in alterations in the protein sequence.
In order to further characterize these S. aureus isolates, whole-genome sequences were determined by high-throughput sequencing using MiSeq (Illumina). Reads were assembled using Velvet (Zerbino & Birney, 2008) and the optimal parameter for the assembly was found using VelvetOptimiser. The spa type and multilocus sequencing type (MLST) were determined using in-house scripts (P. Worning, unpublished).
One isolate (46896-11) was characterized as spa type t4019 and MLST ST152. The other nine isolates were characterized as MLST ST2250. Spa typing of these nine isolates was not possible because of a lack of complete spa types. However, all nine isolates contained between four and 11 spa repeats.
Our results show that PCR for nuc can generate false-negative results because of variations in the DNA sequence of the nuc gene. Consequently, using nuc-specific PCR as the sole molecular method for diagnosing S. aureus infection might result in the misidentification of MRSA as coagulasenegative staphylococci. Incorporation of an additional species-specific target should be considered to increase strain coverage and assay robustness. The observed variations in at least two different genes (nuc and spa) in these clinical strains suggest that major genetic changes have taken place. Further studies on the nature and significance of these changes are clearly warranted. 
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